A. gambiae is the most common vector of human malaria in sub-Saharan Africa, where rates of the disease are highest. The researchers compared the genomes of two emerging species, dubbed M and S. Given that M and S appear to be physically indistinguishable and interbreed often, they were unexpectedly different at the DNA level.
They also were found to behave differently and thrive in different habitats. For example, in the absence of predators, S mosquitoes outcompeted M mosquitoes, but the outcome was reversed when predators were present.
As these two emerging species of mosquito evolve to develop new traits and behaviors, changes in disease transmission could result, the authors say. This could complicate malaria control efforts, which currently are based on the mosquitoes' patterns of behavior and vulnerability to insecticides.
Future research will further investigate these emerging species, exploring how they compete with one another in various habitats and the molecular basis of their evolution. The results will be used to refine existing malaria interventions and inform the development of new disease prevention strategies.
The research was supported by the National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute, both components of NIH. More information about NIAID research on malaria and other vector-borne diseases is available at the NIAID Malaria (http://www.niaid.nih.gov/topics/malaria/Pages/default.aspx) and the NIAID Vector Biology Web portals (http://www.niaid.nih.gov/topics/vector/pages/default.aspx).
ARTICLES: DE Neafsey et al. Complex gene-flow boundaries among vector mosquito populations. Science. DOI: 10.1126/science.1193036 (2010).
MKN Lawniczak et al. Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science. DOI: 10.1126/science.1195755 (2010).
WHO: Adriana Costero-Saint Denis, Ph.D., of the Parasitology and International Programs Branch, NIAID, is available to comment on these articles.
CONTACT: To schedule interviews, please contact Nalini Padmanabhan, 301-402-1663, email@example.com.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases.
Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications
Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State
Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.
Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
09.12.2016 | Life Sciences
09.12.2016 | Ecology, The Environment and Conservation
09.12.2016 | Health and Medicine